American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead Story: Opioid and Naloxone Prescribing Following Insertion of Prompts in the Electronic Health Record to Encourage Compliance With California State Opioid Law

Lead Story: Opioid and Naloxone Prescribing Following Insertion of Prompts in the Electronic Health Record to Encourage Compliance With California State Opioid Law

Tuesday 17th May 2022

Discover how electronic prompts in health records improve opioid prescribing and naloxone use. Learn more key findings in addiction medicine on 'Addiction Medicine Unpacked'.
7 minutes
Informative
Educational
Thought-provoking
Supportive
Engaging

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Smart Prompts: Boosting Safe Opioid Prescribing and Naloxone Use

Adding decision support prompts to the practitioner workflow encourages safe prescribing habits and can mitigate opioid overdose risks.
Ever wondered how a simple electronic prompt could change the landscape of opioid prescribing? This episode of 'Addiction Medicine Unpacked' dives into a fascinating study examining the impact of adding decision support prompts to electronic health records. These prompts were designed to encourage healthcare providers in California to comply with a state law mandating the co-prescription of naloxone for patients at high risk of overdose. The results?
A significant increase in naloxone prescriptions and a decrease in opioid prescribing, showing how technology can foster safer prescribing habits. But that's not all. The episode also sheds light on the stark realities faced by American Indian and Alaska Native populations regarding opioid-related deaths. Over two decades, these communities have seen alarmingly high overdose mortality rates, highlighting the urgent need for equitable access to treatment.
Listeners will also hear about a study exploring the effects of buprenorphine dosage and therapeutic engagement on preventing relapse in opioid use disorder treatment. Spoiler alert: Higher doses and more interaction with clinicians are key to better outcomes.
Additionally, the episode touches on the role of antidepressants in retaining patients in buprenorphine treatment, the feasibility of remote measurement-based care in community addiction treatment settings, and the troubling rise in alcohol use disorder-related deaths during the COVID-19 pandemic, especially among younger adults. Lastly, there's an intriguing discussion on a pre-hospital buprenorphine treatment program run by paramedics. This innovative approach has shown promising results in terms of safety and treatment retention.
Tune in to 'Addiction Medicine Unpacked' for these insights and more, as leading experts break down complex studies into actionable knowledge that can make a real difference.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.